Skip to main content
. 2022 Sep 13;13:953142. doi: 10.3389/fphar.2022.953142

TABLE 2.

Participant demographics (n = 45).

Characteristics Mean (range)
 Age (years) 44 (28–73)
 Years in Practice a 12 (1.5–44)
Gender n (%)
 Female 30 (67.7%)
 Male 15 (33.3%)
Stakeholder Role n (%)
 Physician 14 (31.1%)
 Nurse Practitioner 8 (17.8%)
 Pharmacist 6 (13.3%)
 Physician Assistant 1 (2.2%)
 Administration 5 (11.1%)
 Information Technology 2 (4.4%)
 Informatics 1 (2.2%)
 Other b 8 (17.8%)
Experience with Pharmacogenetics c n (%)
 Agreed with the statement “I am familiar with pharmacogenetic testing” 20 (64.5%)
 Previously ordered a pharmacogenetic test 10 (32.3%)
a

Applicable only to clinical participants.

b

Includes roles of molecular technologist, genetic counselor, dietician, registered nurse, lab technician, and medical records.

c

Only participants from Shodair and PHC were queried about their experience with pharmacogenetics (n = 31).